Sporadic CRC accounts for 70% of new cases, usually following a specific succession of mutations in the adenomatous polyposis coli (APC) gene, followed by KRAS, TP53, and DCC mutations [7]. The gene discussed is TP53; the disease is colorectal carcinoma.